Literature DB >> 23834116

The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application.

S R Dodington1, M K A Basra, A Y Finlay, M S Salek.   

Abstract

The Dermatitis Family Impact (DFI) questionnaire is a disease-specific measure to assess the impact of atopic eczema on the quality of life (QoL) of the parents and family members of affected children. We set out to review the published literature and to collate data on the clinical and psychometric aspects of the DFI questionnaire from its development in 1998-2012, in order to create a single source of reference for users of the DFI. A literature search was performed of publications, including abstracts, describing the use of the DFI between 1998 and 2012. In total, we identified 53 publications (37 full articles and 16 abstracts) describing the use of the DFI in 50 studies. Only one study demonstrated test-retest reliability (r = 0 . 95). Three studies demonstrated internal consistency, with Cronbach α ranging from 0.85 to 0.90. Fifteen studies showed sensitivity to change of DFI scores, with significant differences between baseline and the end of the study. Twenty-six studies correlated the DFI to other objective and subjective instruments to demonstrate its construct (convergent) validity. Seventeen validated translations of the DFI have been used in 16 different countries (including two multinational studies). Nine clinical studies have assessed the effectiveness of five different topical drugs and one probiotic supplement. Two studies have assessed the effectiveness of care by dermatology nurses and dermatologists. The use of the DFI has revealed the major impact of atopic eczema on the QoL of families of affected children. The strengths of the DFI include wide international experience of its use, defined test-retest reliability, good internal consistency, sensitivity to change, and good construct (convergent) validity. Areas requiring further research include creation of validated score descriptors, assessment of minimum important clinical difference and testing of dimensionality, factor structure and differential item functioning.
© 2013 The Authors. BJD © 2013 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2013        PMID: 23834116     DOI: 10.1111/bjd.12232

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Study protocol: assessing SleeP IN infants with early-onset atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study).

Authors:  Cathal O'Connor; Alan D Irvine; Deirdre Murray; Michelle Murphy; Jonathan O'B Hourihane; Geraldine Boylan
Journal:  BMC Pediatr       Date:  2022-06-18       Impact factor: 2.567

2.  Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial.

Authors:  Matthew J Ridd; Niamh M Redmond; Sandra Hollinghurst; Nicola Ball; Lindsay Shaw; Richard Guy; Victoria Wilson; Chris Metcalfe; Sarah Purdy
Journal:  Trials       Date:  2015-07-15       Impact factor: 2.279

3.  Efficacy of the integrative Body-Mind-Spirit group intervention for improving quality of life in parent-child dyads adjusting to atopic dermatitis: protocol for a randomised controlled trial.

Authors:  Victoria Ka Ying Hui; Celia Hoi Yan Chan; Yat Lui Fung; Cecilia Lai Wan Chan; Martha Sin Ki Luk
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

4.  Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study.

Authors:  Jee Woong Choi; Yul Hee Kim; Hyunbin Kwak; Jin Park; Won-Soo Lee; Hoon Kang; Jung Eun Kim; Tae-Young Yoon; Ki-Ho Kim; Yong Hyun Jang; Do Won Kim; Moon-Bum Kim; Bark-Lynn Lew; Woo-Young Sim; Jiehyun Jeon; Soo Hong Seo; Ohsang Kwon; Chang-Hun Huh; Dong-Youn Lee; Yang Won Lee; Byung Choel Park; Chong Hyun Won; Do Young Kim; Hyojin Kim; Beom Joon Kim; Young Lee; Sang Seok Kim; Gwang Seong Choi
Journal:  Ann Dermatol       Date:  2022-08       Impact factor: 0.722

Review 5.  Counting the Burden: Atopic Dermatitis and Health-related Quality of Life.

Authors:  Faraz Ali; Jui Vyas; Andrew Y Finlay
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

6.  Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families.

Authors:  Eric L Simpson; Amy S Paller; Mark Boguniewicz; Lawrence F Eichenfield; Steven R Feldman; Jonathan I Silverberg; Sarah L Chamlin; Lee T Zane
Journal:  Dermatol Ther (Heidelb)       Date:  2018-10-22

7.  Development of a Pediatric Dermatology Screening Tool Based on Two Parent-Reported Skin Symptoms: Comparison of Parental Recognition and Physician Diagnosis of Skin Symptoms of Infants and Toddlers.

Authors:  Hiroko Sato; Aya Goto; Michio Murakami; Yasuhiro Kawabata
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

8.  Systematic review of psychosocial needs assessment tools for caregivers of paediatric patients with dermatological conditions.

Authors:  Carleen Walsh; Gerard Leavey; Marian McLaughlin
Journal:  BMJ Open       Date:  2022-01-19       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.